Study details
Enrolling now
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
Yale University
NCT IDNCT06027840ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
40
Study length
about 1.8 years
Ages
18+
Locations
1 site in CT
What this study is about
Researchers are testing whether quitting both cigarettes and e-cigarettes at the same time (concurrent) or first quitting cigarettes then e-cigarettes (sequential) is more effective for quitting both products. The trial will also compare how these treatments affect health markers.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Counseling
- 2.Participate in Guided Self-Change Booklets
- 3.Take Varenicline
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
varenicline
Drug routes
oral (Oral Tablet)